JP2015523346A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015523346A5 JP2015523346A5 JP2015516261A JP2015516261A JP2015523346A5 JP 2015523346 A5 JP2015523346 A5 JP 2015523346A5 JP 2015516261 A JP2015516261 A JP 2015516261A JP 2015516261 A JP2015516261 A JP 2015516261A JP 2015523346 A5 JP2015523346 A5 JP 2015523346A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- neutropenia
- retinoid agonist
- pharmaceutical composition
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261656815P | 2012-06-07 | 2012-06-07 | |
| US61/656,815 | 2012-06-07 | ||
| PCT/US2013/044828 WO2013185105A1 (en) | 2012-06-07 | 2013-06-07 | Methods for treating neutropenia using retinoid agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015523346A JP2015523346A (ja) | 2015-08-13 |
| JP2015523346A5 true JP2015523346A5 (cg-RX-API-DMAC7.html) | 2016-06-16 |
| JP6295249B2 JP6295249B2 (ja) | 2018-03-14 |
Family
ID=49712715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015516261A Expired - Fee Related JP6295249B2 (ja) | 2012-06-07 | 2013-06-07 | レチノイドアゴニストを用いた好中球減少症の治療方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11116738B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2858636B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6295249B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102083046B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN104519879B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2013270674B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112014030279A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2874850A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2691493T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX365321B (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ702415A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2650962C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013185105A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11116738B2 (en) | 2012-06-07 | 2021-09-14 | Children's Hospital Los Angeles | Methods for treating neutropenia using retinoid agonists |
| JP2016518342A (ja) | 2013-03-15 | 2016-06-23 | アヴィセンナ・コスメティクス・エルエルシーAvisenna Cosmetics, Llc | 加齢の影響を軽減するための局所組成物 |
| WO2015126989A1 (en) * | 2014-02-18 | 2015-08-27 | Children's Hospital Los Angeles | Compositions and methods for treating neutropenia |
| CN116059365A (zh) | 2015-03-31 | 2023-05-05 | 希洛斯医药品股份有限公司 | 对使用维甲酸受体-α激动剂治疗的患者进行分层的方法 |
| US9868994B2 (en) | 2016-04-08 | 2018-01-16 | Syros Pharmaceuticals, Inc. | Methods of stratifying patients for treatment with retinoic acid receptor-α agonists |
| WO2018067946A1 (en) * | 2016-10-06 | 2018-04-12 | Syros Pharmaceuticals, Inc. | Methods of treating patients with a retinoic acid receptor-alpha agonist and an anti-cd38 antibody |
| CN111971557A (zh) * | 2018-01-26 | 2020-11-20 | 新加坡科技研究局 | 嗜中性粒细胞亚型 |
| CN113969261B (zh) * | 2020-07-06 | 2024-04-09 | 苏州市立医院(北区) | 三步法快速测定中性粒细胞趋化的方法 |
| US20220378727A1 (en) * | 2021-05-14 | 2022-12-01 | The University Of Hong Kong | Dry powder formulations of tamibarotene for pulmonary and intranasal delivery |
| FI131561B1 (en) * | 2023-12-28 | 2025-06-30 | Faron Pharmaceuticals Oy | CLEVER-1 INHIBITOR TO PROMOTE HEMATOLOGICAL RECOVERY WHEN USING CHEMOTHERAPY |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5691196A (en) * | 1992-12-31 | 1997-11-25 | American Cyanamid Company | Recombinant nucleic acid containing a response element |
| US5965606A (en) | 1995-12-29 | 1999-10-12 | Allergan Sales, Inc. | Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity |
| WO1998026781A1 (en) * | 1996-12-19 | 1998-06-25 | American Cyanamid Company | Method of treating or inhibiting neutropenia |
| AU2001290846B2 (en) | 2000-09-08 | 2006-02-02 | Massachusetts Institute Of Technology | G-CSF analog compositions and methods |
| US7119061B2 (en) | 2002-11-18 | 2006-10-10 | Vicuron Pharmaceuticals, Inc. | Dalbavancin compositions for treatment of bacterial infections |
| AR044315A1 (es) | 2003-05-16 | 2005-09-07 | Kyowa Hakko Kogyo Kk | Agente para prevenir y/o tratar enfermedades acompañadas de alteraciones de tejidos que comprende un polipeptido |
| EP1621191A1 (en) | 2004-07-29 | 2006-02-01 | Werner Bollag | Treatment of inflammatory diseases by RXR Antagonists |
| CN101094684A (zh) | 2004-08-13 | 2007-12-26 | 阿诺麦德股份有限公司 | 用趋化因子的组合活化祖细胞/干细胞 |
| DK1841432T3 (da) | 2004-12-02 | 2010-12-06 | Venus Remedies Ltd | Sammensætninger til bekæmpelse af Beta-lactamase-medieret antibiotisk resistens ved anvendelse af Beta-lactamase-hæmmere, der er anvendelige til injektion |
| US20090111786A1 (en) * | 2004-12-03 | 2009-04-30 | Glass Christopher K | Compounds that Prevent Macrophage Apoptosis and Uses Thereof |
| CN101472572B (zh) * | 2006-05-16 | 2012-10-10 | Io治疗有限责任公司 | Rar拮抗剂或反向激动剂在治疗化学疗法和/或放射疗法副作用中的用途 |
| NZ580209A (en) * | 2007-03-30 | 2011-11-25 | Tmrc Co Ltd | Tamibarotene capsule preparation |
| BRPI0819887A2 (pt) * | 2007-12-06 | 2017-05-23 | Csl Ltd | métodos e agentes para inibição de celulas-tronco leucêmicas, e para o tratamento de uma condição de câncer hematológico em um paciente, e, uso de uma molécula de ligação a antigeno |
| EP2604702B1 (en) | 2008-09-05 | 2015-07-01 | The University of Chicago | Methods for direct detection of DNA damage |
| EP2490543B1 (en) | 2009-10-19 | 2015-07-22 | Laila Nutraceuticals | Extracts, fractions and compositions comprising acetogenins and their applications |
| RU2446173C1 (ru) | 2010-08-13 | 2012-03-27 | Зао "Биокад" | Новый функционально активный, высокоочищенный стабильный конъюгат гранулоцитарного колониестимулирующего фактора (г-ксф) с полиэтиленгликолем с пролонгированным биологическим действием, пригодный для медицинского применения, и иммунобиологическое средство на его основе |
| CN102380090A (zh) | 2010-08-31 | 2012-03-21 | 健能隆医药技术（上海）有限公司 | G-csf二聚体在治疗嗜中性粒细胞减少症中的应用 |
| CA2826386C (en) | 2011-02-08 | 2020-04-28 | Cellular Dynamics International, Inc. | Hematopoietic precursor cell production by programming |
| JP6242868B2 (ja) * | 2012-05-08 | 2017-12-06 | リセラ・コーポレイションＬｙｃｅｒａ Ｃｏｒｐｏｒａｔｉｏｎ | ＲＯＲγのアゴニストとしての使用のためおよび疾患の処置のためのテトラヒドロ［１，８］ナフチリジンスルホンアミドおよび関連化合物 |
| US11116738B2 (en) | 2012-06-07 | 2021-09-14 | Children's Hospital Los Angeles | Methods for treating neutropenia using retinoid agonists |
| DE102012011766B3 (de) | 2012-06-15 | 2013-12-19 | Voith Patent Gmbh | Getriebeeinheit |
| CN110946993A (zh) | 2014-01-03 | 2020-04-03 | 上海泽生科技开发股份有限公司 | 纽兰格林制剂的配方 |
| WO2015126989A1 (en) | 2014-02-18 | 2015-08-27 | Children's Hospital Los Angeles | Compositions and methods for treating neutropenia |
-
2013
- 2013-06-07 US US14/405,141 patent/US11116738B2/en active Active
- 2013-06-07 WO PCT/US2013/044828 patent/WO2013185105A1/en not_active Ceased
- 2013-06-07 AU AU2013270674A patent/AU2013270674B2/en not_active Ceased
- 2013-06-07 EP EP13800873.5A patent/EP2858636B1/en not_active Not-in-force
- 2013-06-07 CN CN201380041537.6A patent/CN104519879B/zh not_active Expired - Fee Related
- 2013-06-07 CA CA2874850A patent/CA2874850A1/en not_active Abandoned
- 2013-06-07 ES ES13800873.5T patent/ES2691493T3/es active Active
- 2013-06-07 KR KR1020157000014A patent/KR102083046B1/ko not_active Expired - Fee Related
- 2013-06-07 RU RU2014153988A patent/RU2650962C2/ru not_active IP Right Cessation
- 2013-06-07 NZ NZ702415A patent/NZ702415A/en not_active IP Right Cessation
- 2013-06-07 JP JP2015516261A patent/JP6295249B2/ja not_active Expired - Fee Related
- 2013-06-07 MX MX2014014930A patent/MX365321B/es active IP Right Grant
- 2013-06-07 BR BR112014030279A patent/BR112014030279A2/pt not_active Application Discontinuation